Remarkably, the hypothesis that bone damage in RA precedes the clinical onset of disease is supported by the discovery of systemic bone loss and cortical bone erosion in a cohort of healthy ACPA-positive individuals (5), suggesting that ACPA directly trigger bone loss. Here, PRTN3 is linked to rheumatoid arthritis.